Q2 Holdings, Inc. (QTWO): what the price assumes
In the published model solve dated 2026-Q2, anchored at $63.64, Q2 Holdings, Inc. (QTWO) is priced for today's economics sustained for ~17.7 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/QTWO
Headline
| Field | Value |
|---|---|
| Ticker | QTWO |
| Company | Q2 Holdings, Inc. |
| Current price | $63.64/sh |
| Composition | Subscription 82% / Transactional 9% / Services and Other 10% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 12.0% |
| Operating margin today | 10.0% |
| Margin expansion (value-band) | +2.0pp |
| Must persist for | 17.7y |
| Multiple paid | 46x operating income |
The operating-margin figure is value-band context at year 8: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 13% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.7 years.
Reconcile: at the x-ray's 9.3% required return this reads ~9.2 years; the models below use their own rates.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| vs own history | +0.61σ |
| cohort percentile (of 187 peers) | 76 |
| sustained it ~10 years at this level | 15% |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 3.52x | 5 | expensive |
| Earnings | 2.29x | 4 | expensive |
| Relative | 1.21x | 5 | expensive |
| Growth | 0.98x | 3 | justifies |
Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.
Per-Model Detail (n=17)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $75.02 | 0.85x | yes | FCF base $0.2B, growth 14% (input: historical growth), terminal g 4.0%, WACC 9.0%, 6yr projection |
| DCF Exit Multiple | Growth | $64.73 | 0.98x | yes | Exit EV/EBITDA: 39.1x / 41.1x / 43.1x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $52.47 | 1.21x | yes | P/E 35x (static sector reference · 2026-04), scenarios: 28.9x / 35.0x / 41.1x (bear / base = reference held flat / bull), EV/EBITDA 29.84x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $15.95 | 3.99x | yes | BV/sh $10.32, ROE (TTM) 14.3%, ke 9.3% |
| Two-Stage Excess Return | Asset | $19.61 | 3.25x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $46.64 | 1.36x | yes | Rev $0.8B, growth 14% (input: historical growth; tapered), Terminal P/S: 3.9x / 4.7x / 5.5x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $16.92 | 3.76x | yes | EPS $1.41, growth 2% (input: historical EPS growth), PEG=21.57 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | $20.22 | 3.15x | yes | BV $10.32 + 5yr PV of (ROE (TTM) 14.3% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $18.09 | 3.52x | yes | √(22.5 × EPS $1.41 × BVPS $10.32) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $38.63 | 1.65x | yes | EBITDA $0.10B × sector EV/EBITDA 25.0x |
| FCF Yield | Earnings | $36.86 | 1.73x | yes | FCF $213.2M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $22.25 | 2.86x | yes | SBC-adj FCF $0.13B (FCF $0.21B − SBC $0.08B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $45.50 | 1.40x | yes | EPS $1.41 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $4.85 | 13.12x | yes | BV $10.32 × (ROIC 4.2% / WACC 9.0%) |
| P/Sales Sector | Relative | $108.57 | 0.59x | yes | Revenue $0.85B × sector P/S 8.0x |
| PEG Fair Value | Relative | $52.88 | 1.20x | yes | EPS $1.41 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $15.24 | 4.18x | yes | EPS $1.41 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Q2 Holdings (consolidated) | operating | enterprise | 0.8B reported-currency | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net cash | $106.4m |
| Net debt / NOPAT (after-tax) | -1.33x (net cash) |
| Net debt / operating income (pre-tax) | -1.25x (net cash) |
| Share count CAGR (dilution) | 3.4% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
The trajectory is the story. Q1 2026 revenue rose to $216.5 million from $189.7 million, net income jumped to $26.6 million from $4.8 million, gross margin widened to 62.1% from 57.9%, and adjusted EBITDA hit a record $60 million, about 28% of revenue. A SaaS business is crossing from growth-at-all-costs into real profitability.
The price has already priced much of that turn and then some. At $42.87 the market pays roughly 52 times company-wide operating income, which on the current 8% operating margin implies the company holds its self-funding growth ceiling for about 16 years. Only about 15% of comparable fast-growers have sustained such a run.
The methods split as a long-duration growth bet should. The perpetual-growth DCF near $69 and relative valuation near $38 reach the price; the asset and earnings-floor methods, near $12 to $16, sit far below. The balance sheet is clean (net cash, strong free cash flow), so the debate is duration, not solvency.
Bull Case
Follow the direction the numbers have moved over the past year and the bull case is a profitability inflection, not a hope. In the first quarter of 2026 revenue grew to $216.5 million from $189.7 million a year earlier, but the more important shift was below the top line: net income rose to $26.6 million from $4.8 million, gross margin expanded to 62.1% from 57.9%, and adjusted EBITDA reached a record $60 million, about 28% of revenue. Operating cash flow was $56.3 million. A digital-banking SaaS company that spent years investing through losses is now converting growth into cash, and the rate of margin improvement is the signal that the model scales.
The recurring base gives that improvement durability. Subscription revenue is roughly 83% of the total, and subscription annual recurring revenue reached $802.3 million, up about 14% year over year, with total ARR near $944.9 million. The company sells "banking platform solutions based on the number of solutions purchased by our customers and the number of Registered Users" and earns additional revenue as those bases grow (FY2024 10-K, accession 0001410384-25-000010). That land-and-expand structure, banks and credit unions adding solutions and users over multi-year contracts, is exactly the kind of sticky revenue that supports the long-duration value the price embeds.
Management is backing the turn with capital return and raised targets. The company repurchased $97.2 million of stock in the quarter and guided full-year 2026 revenue to $875 million to $882 million with adjusted EBITDA of $237 million to $242 million. A balance sheet in a net cash position, free cash flow funding buybacks, and a guided EBITDA margin near 27% mean the profitability story is not a one-quarter artifact. For the bull, QTWO is a recurring-revenue platform at the moment its operating leverage becomes visible, and the relative and growth-DCF methods (near $38 and $69) support paying up for that inflection.
Bear Case
The bear case is about what the price assumes, and the assumption is heroic. At $42.87 (June 28, 2026) the market pays roughly 52 times company-wide operating income, which on the current 8% operating margin requires Q2 to hold its self-funding growth ceiling for about 16 years. That is the single most fragile thing baked into the price. Only about 15% of comparable fast-growers have sustained such a pace for even a decade, let alone sixteen years. The valuation is not pricing the profitability turn that has happened; it is pricing a second decade-plus of compounding that has not, and the methods that anchor to today's economics show the gap starkly: simple excess return near $12, residual income near $14, Graham number near $15, all a fraction of the price. The reasonable-growth band the model produces centers near $12.
The growth that must persist is already decelerating. Subscription ARR grew about 14% year over year, solid but a step down from the hypergrowth a sixteen-year duration assumption needs, and investors have specifically reacted to slowing ARR growth and the pressure on software margins. The company's own description of the business names the constraint: the implementation process for digital banking is lengthy and intensive, with no immediate plans to significantly speed it up. Long implementation cycles cap how fast new logos convert to revenue, which is the throttle on the very durability the price depends on.
The competitive and structural realities tighten the screw. Q2 sells into community and regional banks and credit unions, a customer base that is consolidating and that faces its own margin pressure, and it competes against larger core-banking incumbents and a wave of fintech platforms. The bet embedded in the price is that this customer set keeps expanding solutions and users for a decade and a half while margins keep climbing. Strip that to a more normal SaaS fade, and the price has little support beneath it: the asset and earnings methods sit near $15, the relative method near $38, and the only method that reaches the quote is a growth-DCF that itself assumes years of double-digit growth. A net-cash balance sheet removes the solvency risk, but it does nothing for the duration risk, which is the whole bet.
Valuation
The inversion runs in duration mode because Q2's current margin is thin (about 8% at the operating line) relative to a high price. At $42.87 the market pays roughly 52 times company-wide operating income, which solves to the company holding its self-funding growth ceiling for about 16 years at an 11.9% cost of capital. Each one-point change in the cost of capital moves the implied horizon about 2.5 years. The near-term growth rate is within recent history; the priced-in assumption is elevated because of how long the growth must persist, and only about 15% of comparable fast-growers have sustained such a run.
The method families sort cleanly into a growth bet. The growth and relative families reach or approach the price: perpetual-growth DCF near $69, exit-multiple DCF near $47, relative valuation near $38, discounted-future-market-cap near $31. The asset and earnings families sit far below: simple excess return near $12, two-stage excess return near $13, residual income near $14, Graham number near $15, with earnings power value not applicable because normalized operating profit does not yet clear the cost of capital. The blended central estimate is about $26, and the reasonable-growth band centers near $12, both well below the price.
The reconciliation is what a long-duration software bet looks like: the relative-multiple and growth-DCF methods justify the price, while the asset and earnings-power methods say it is expensive against current economics. For a recurring-revenue platform mid-inflection, the forward methods are the more relevant lens, but the spread between them and the asset methods is unusually wide, which is the model's way of flagging how much of the value sits in years that have not happened. One measurement note: the trailing operating-income figure used in the inversion and the EDGAR quarterly measure diverge here, so treat the 52x multiple as approximate. The balance sheet is a non-issue, with net cash near $75 million and interest coverage above 60 times; the entire question is durability.
Catalysts
The defining recent catalyst was the first-quarter 2026 report. Revenue grew to $216.5 million, net income rose to $26.6 million from $4.8 million, gross margin expanded to 62.1%, and adjusted EBITDA hit a record $60 million (about 28% of revenue). Management guided full-year 2026 revenue to $875 million to $882 million and adjusted EBITDA to $237 million to $242 million, and repurchased $97.2 million of stock in the quarter. The pace of margin expansion against that guidance is the most important marker for the thesis.
The key swing factor is subscription ARR growth, which ran about 14% year over year. Because the price embeds many years of sustained growth, any further deceleration, or reacceleration, in ARR is the catalyst that moves the stock most. Investors have already shown sensitivity to slowing ARR and software-margin pressure, so each quarter's ARR print and net retention read carries outsized weight.
The structural factors to monitor are the lengthy digital-banking implementation cycle, which caps how fast new contracts convert to revenue, and the AI-driven product initiatives management has highlighted as a growth lever. Continued buybacks funded by free cash flow are the offsetting positive worth tracking.
Sources: Q2 Holdings Q1 2026 results (businesswire.com, stocktitan.net, gurufocus.com, Yahoo Finance), Investing.com SWOT analysis.
Peer Cohorts (Per Segment, With Filing Citations)
Q2 Holdings (consolidated) (reported)
- GWRE (Guidewire Software, Inc.)
- FY2025 10-K: …stock (or, in the event the conversion is settled in cash, to reduce its cash payment obligation) in the event that at the time of conversion its stock price exceeds the conversion price under the Convertible Senior Notes. The Capped Calls are subject to either adjustment or termination upon the occurrence of…
- FY2025 10-K: …Basis of Presentation and Consolidation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"). The consolidated financial statements and notes include the Company and its wholly-owned subsidiaries and reflect all…
- VEEV (Veeva Systems Inc.)
- FY2025 10-K: …in interest rates occur. Fluctuations in the value of our investment securities caused by a change in interest rates (gains or losses on the carrying value) are recorded in other comprehensive income, and are realized only if we sell the underlying securities. Veeva Systems Inc. | Form 10-K 47 Table of Contents ITEM…
- FY2025 10-K: …Accounting Firm 49 Consolidated Balance Sheets 51 Consolidated Statements of Comprehensive Income 52 Consolidated Statements of Stockholders' Equity 53 Consolidated Statements of Cash Flows 54 Notes to Consolidated Financial Statements 55 Note 1. Summary of Business and Significant Accounting Policies 55 Note 2.…
- APPF (AppFolio, Inc.)
- FY2025 10-K: …are an integral part of these statements. 41 APPFOLIO, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (in thousands) Accumulated Additional Other Common Stock Common Stock Paid-in Comprehensive Treasury Retained Class A Class B Capital (Loss) Income Stock Earnings Total Shares Amount Shares Amount Balance at…
- FY2025 10-K: …Registered Public Accounting Firm (PCAOB ID 238 ) 37 Consolidated Balance Sheets 39 Consolidated Statements of Operations 40 Consolidated Statements of Comprehensive (Loss) Income 41 Consolidated Statements of Stockholders' Equity 42 Consolidated Statements of Cash Flows 43 Notes to Consolidated Financial Statements…
- ALKT (ALKAMI TECHNOLOGY, INC.)
- FY2025 10-K: …period. Capped Calls In connection with the 2030 Convertible Notes, the Company has entered into privately negotiated capped call transactions with certain financial institutions pursuant to capped call confirmations (collectively, the "Capped Calls"). The premiums paid for the purchases of the Capped Calls were…
- FY2025 10-K: …subsidiary of the Company. MANTL provides onboarding and account opening solutions that allow FIs to acquire commercial, business and retail customers through a variety of channels for many deposit account types. The aggregate consideration paid in exchange for all of the outstanding equity interests of MANTL was…
- NCNO (nCino, Inc.)
- FY2025 10-K: …financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by the Company's management are used for, but not limited to, revenue recognition including determining the nature and timing of satisfaction of performance obligations,…
- FY2025 10-K: …on Form 10-K. 2. Financial Statement Schedules The Financial Statement Schedules have been omitted because they are not required, not applicable, or the required information is included in the Consolidated Financial Statements or Notes thereto. 3. Exhibits The exhibits listed in the Exhibit Index below are filed or…
- SEMR (Semrush Holdings, Inc.)
- FY2025 10-K: …option agreement with the borrower in which the Company had the right, but not the obligation, to acquire a majority of the outstanding common stock of the borrower during the period beginning July 1, 2024 and ending August 31, 2024. The Company accounted for the loan agreement and option agreement as a single…
- FY2025 10-K: …Holdings, Inc., Adobe Inc. and Fenway Merger Sub. Inc., dated November 18, 2025. 8-K 001-40276 2.1 11/19/2025 3.1 Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect . S-1/A 333-253730 3.2 3/16/2021 3.2 Certificate of Amendment of the Amended and Restated Certificate of…
- KVYO (Klaviyo, Inc.)
- FY2025 10-K: …publicly stated revenue or earnings forecasts that we may provide. The dual series structure of our common stock has the effect of concentrating voting control with those stockholders who hold shares of our Series B common stock, including our directors, executive officers, and their respective affiliates, and…
- FY2025 10-K: …corporate bonds, and commercial paper to reduce our global exposure on banking deposits. Lease Obligations We enter into various noncancellable lease agreements for certain office space and equipment used in the normal course of business. Our noncancellable lease obligations as of December 31, 2025 were $150.8…
- BRZE (Braze, Inc.)
- FY2025 10-K: …directors and significant holders of our capital stock, which limits the ability of holders of our Class A common stock to influence the outcome of important transactions. Our Class B common stock has ten votes per share and our Class A common stock, which is the stock listed on the Nasdaq Global Select Market, has…
- FY2025 10-K: 1,789 1,662 Accrued tax liability 8,848 9,048 ESPP payable 612 594 Other 2,399 5,097 Total accrued expenses and other current liabilities $ 64,189 $ 63,264 10. Employee Benefit Plans We sponsor a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary.…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.